4103-88-2 → HCID 21434432, compound
Reaction equation
[N:1]1([C:6]([N:8]2[CH2:14][CH2:13][C:12]3[CH:15]=[CH:16][C:17]([S:19]([NH2:22])(=[O:21])=[O:20])=[CH:18][C:11]=3[CH2:10][CH2:9]2)=[O:7])[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH:23]1([N:29]=[C:30]=[O:31])[CH2:28][CH2:27][CH:26]=[CH:25][CH2:24]1>>[CH:23]1([NH:29][C:30]([NH:22][S:19]([C:17]2[CH:16]=[CH:15][C:12]3[CH2:13][CH2:14][N:8]([C:6]([N:1]4[CH2:5][CH2:4][CH2:3][CH2:2]4)=[O:7])[CH2:9][CH2:10][C:11]=3[CH:18]=2)(=[O:21])=[O:20])=[O:31])[CH2:28][CH2:27][CH:26]=[CH:25][CH2:24]1Participants
3
Procedure
By the reaction of 2,3,4,5-tetrahydro-3-(1-pyrrolidinylcarbonyl)-1H-3-benzazepin-7-sulfonamide and 3-cyclohexen-1-ylisocyanate in a manner analogous to that described in Example 1, there is obtained 1-(3-cyclohexen-1-yl)-3-{[2,3,4,5-tetrahydro-3-(1-pyrrolidinylcarbonyl)-1H-3-benzazepin-7-yl]sulfonyl}urea, m.p. 211°-212° C.
Sources & evidence
- ORD record
- ord-9b5172a1e0e946a2b67af2a6df16e626
- Source dataset
- uspto-grants-1977_05
- Patent number
- US04024128
Reaction notes
Loading…